Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.

Tin-Chen Hsu(Science Applications International Corporation (United States)), Nancy H. Colburn(Gene Therapy Laboratory), Glenn Hegamyer(Roswell Park Comprehensive Cancer Center), Preety Tulsian(Cancer Institute (WIA)), Rajesh Nair(St Thomas' Hospital), Corinne E. Camalier(National Cancer Institute), Mathew R. Young(Frederick National Laboratory for Cancer Research)
PubMed
May 15, 2001
Cited by 44


Related Papers